Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications

Article ID	Journal	Published Year	Pages	File Type
5693167	European Urology	2017	11 Pages	PDF

Abstract

Absolute rates of biopsy and postbiopsy complications have decreased following landmark publications about prostate-specific antigen screening; however, the relative morbidity of biopsy continues to increase.

Keywords

randomized trials Prostate biopsy Complications PSA screening Guidelines

Related Topics

Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health

Preview

Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications

Authors

Boris Gershman, Holly K. Van Houten, Jeph Herrin, Daniel M. Moreira, Simon P. Kim, Nilay D. Shah, R. Jeffrey Karnes,